152 related articles for article (PubMed ID: 22400076)
1. Prognostic value of histological features in diffuse astrocytomas WHO grade II.
Lind-Landström T; Habberstad AH; Sundstrøm S; Torp SH
Int J Clin Exp Pathol; 2012; 5(2):152-8. PubMed ID: 22400076
[TBL] [Abstract][Full Text] [Related]
2. Proliferative activity and histopathological features in diffuse grade II astrocytomas.
Lind-Landström T; Habberstad AH; Torp SH
APMIS; 2012 Aug; 120(8):640-7. PubMed ID: 22779687
[TBL] [Abstract][Full Text] [Related]
3. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
[TBL] [Abstract][Full Text] [Related]
4. The clinical value of Ki-67/MIB-1 labeling index in human astrocytomas.
Johannessen AL; Torp SH
Pathol Oncol Res; 2006; 12(3):143-7. PubMed ID: 16998593
[TBL] [Abstract][Full Text] [Related]
5. Cellular proliferation in pilocytic and diffuse astrocytomas.
Giannini C; Scheithauer BW; Burger PC; Christensen MR; Wollan PC; Sebo TJ; Forsyth PA; Hayostek CJ
J Neuropathol Exp Neurol; 1999 Jan; 58(1):46-53. PubMed ID: 10068313
[TBL] [Abstract][Full Text] [Related]
6. Expression and clinical significance of the proliferation marker minichromosome maintenance protein 2 (Mcm2) in diffuse astrocytomas WHO grade II.
Lind-Landström T; Varughese RK; Sundstrøm S; Torp SH
Diagn Pathol; 2013 Apr; 8():67. PubMed ID: 23618321
[TBL] [Abstract][Full Text] [Related]
7. Mitosin and pHH3 predict poorer survival in astrocytomas WHO grades II and III.
Varughese RK; Lind-Landström T; Habberstad AH; Salvesen Ø; Haug CS; Sundstrøm S; Torp SH
J Clin Pathol; 2016 Jan; 69(1):26-34. PubMed ID: 26188054
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas.
Wakimoto H; Aoyagi M; Nakayama T; Nagashima G; Yamamoto S; Tamaki M; Hirakawa K
Cancer; 1996 Jan; 77(2):373-80. PubMed ID: 8625247
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological features, MIB-1 labeling index and apoptotic index in recurrent astrocytic tumors.
Ralte AM; Sharma MC; Karak AK; Mehta VS; Sarkar C
Pathol Oncol Res; 2001; 7(4):267-78. PubMed ID: 11882906
[TBL] [Abstract][Full Text] [Related]
10. Role of Ki-67 labeling index as an adjunct to the histopathological diagnosis and grading of astrocytomas.
Thotakura M; Tirumalasetti N; Krishna R
J Cancer Res Ther; 2014; 10(3):641-5. PubMed ID: 25313753
[TBL] [Abstract][Full Text] [Related]
11. Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas.
Colman H; Giannini C; Huang L; Gonzalez J; Hess K; Bruner J; Fuller G; Langford L; Pelloski C; Aaron J; Burger P; Aldape K
Am J Surg Pathol; 2006 May; 30(5):657-64. PubMed ID: 16699322
[TBL] [Abstract][Full Text] [Related]
12. Practical value of MIB-1 index in predicting behavior of astrocytomas.
Ambroise MM; Khosla C; Ghosh M; Mallikarjuna VS; Annapurneswari S
Indian J Pathol Microbiol; 2011; 54(3):520-5. PubMed ID: 21934213
[TBL] [Abstract][Full Text] [Related]
13. Analysis of proliferation and apoptosis in brain gliomas: prognostic and clinical value.
Heesters MA; Koudstaal J; Go KG; Molenaar WM
J Neurooncol; 1999; 44(3):255-66. PubMed ID: 10720205
[TBL] [Abstract][Full Text] [Related]
14. The proliferative potential of the pilocytic astrocytoma: the relation between MIB-1 labeling and clinical and neuro-radiological follow-up.
Dirven CM; Koudstaal J; Mooij JJ; Molenaar WM
J Neurooncol; 1998 Mar; 37(1):9-16. PubMed ID: 9525833
[TBL] [Abstract][Full Text] [Related]
15. Expression of Ki-67, topoisomerase IIalpha and c-MYC in astrocytic tumors: correlation with the histopathological grade and proliferative status.
Faria MH; Gonçalves BP; do Patrocínio RM; de Moraes-Filho MO; Rabenhorst SH
Neuropathology; 2006 Dec; 26(6):519-27. PubMed ID: 17203587
[TBL] [Abstract][Full Text] [Related]
16. Cyclin D1 and MIB-1 immunohistochemistry in pilocytic astrocytomas: a study of 48 cases.
Machen SK; Prayson RA
Hum Pathol; 1998 Dec; 29(12):1511-6. PubMed ID: 9865840
[TBL] [Abstract][Full Text] [Related]
17. Impact of proliferation index on outcome in childhood malignant gliomas: results in a multi-institutional cohort.
Pollack IF; Hamilton RL; Burnham J; Holmes EJ; Finkelstein SD; Sposto R; Yates AJ; Boyett JM; Finlay JL
Neurosurgery; 2002 Jun; 50(6):1238-44; discussion 1244-5. PubMed ID: 12015841
[TBL] [Abstract][Full Text] [Related]
18. MIB-1 proliferation index predicts survival among patients with grade II astrocytoma.
McKeever PE; Strawderman MS; Yamini B; Mikhail AA; Blaivas M
J Neuropathol Exp Neurol; 1998 Oct; 57(10):931-6. PubMed ID: 9786243
[TBL] [Abstract][Full Text] [Related]
19. Expression of phosphoprotein enriched in astrocytes 15 kDa (PEA-15) in astrocytic tumors: a novel approach of correlating malignancy grade and prognosis.
Watanabe Y; Yamasaki F; Kajiwara Y; Saito T; Nishimoto T; Bartholomeusz C; Ueno NT; Sugiyama K; Kurisu K
J Neurooncol; 2010 Dec; 100(3):449-57. PubMed ID: 20455002
[TBL] [Abstract][Full Text] [Related]
20. Gliomas of the optic nerve: histological, immunohistochemical (MIB-1 and p53), and MRI analysis.
Cummings TJ; Provenzale JM; Hunter SB; Friedman AH; Klintworth GK; Bigner SH; McLendon RE
Acta Neuropathol; 2000 May; 99(5):563-70. PubMed ID: 10805102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]